Rohwedder et al. reported that pFN may promote plaque rupture and arterial occlusion by regulating FN production, while vascular FN deposits serve as a trigger for vascular SMC recruitment, strongly opposing the therapeutic strategy of blocking FN function to treat atherosclerosis [27]. The gene discussed is FN1; the disease is atherosclerosis.